4//SEC Filing
Gilmour Duncan 4
Accession 0001062993-23-006628
CIK 0001036262other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 4:36 PM ET
Size
12.1 KB
Accession
0001062993-23-006628
Insider Transaction Report
Form 4
INTEST CORPINTT
Gilmour Duncan
CFO, Treasurer & Secretary
Transactions
- Award
Common Stock
2023-03-08+4,672→ 26,276 total - Award
Common Stock
2023-03-08+4,670→ 30,946 total - Award
Employee Stock Option (right to buy)
2023-03-08+8,044→ 8,044 totalExercise: $16.06Exp: 2033-03-07→ Common Stock (8,044 underlying)
Holdings
- 200(indirect: By Spouse)
Common Stock
- 8,104
Employee Stock Option (right to buy)
Exercise: $16.80Exp: 2031-06-13→ Common Stock (8,104 underlying) - 12,848
Employee Stock Option (right to buy)
Exercise: $9.76Exp: 2032-03-08→ Common Stock (12,848 underlying)
Footnotes (5)
- [F1]These restricted shares were granted pursuant to the Issuer's Fourth Amended and Restated 2014 Stock Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 8, 2024
- [F2]These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 8, 2026 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 7,005.
- [F3]This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 8, 2024
- [F4]This option vests in four equal annual installments commencing on March 9, 2023.
- [F5]This option vests in four equal annual installments commencing on June 14, 2022.
Issuer
INTEST CORP
CIK 0001036262
Entity typeother
Related Parties
1- filerCIK 0001866719
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 4:36 PM ET
- Size
- 12.1 KB